Skip to main content
Clinical Trials/ACTRN12618001314213
ACTRN12618001314213Not yet recruitingPhase 1

An efficacy study in healthy malaria-naive adults for purified Plasmodium falciparum 7G8 parasites attenuated with Tafuramycin-A

Griffith University0 sites36 target enrollmentStarted: August 6, 2018Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Enrollment
36

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 50 Years (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Similar Trials